138 related articles for article (PubMed ID: 18618331)
21. Lipidic implants for controlled release of bioactive insulin: effects on cartilage engineered in vitro.
Appel B; Maschke A; Weiser B; Sarhan H; Englert C; Angele P; Blunk T; Göpferich A
Int J Pharm; 2006 May; 314(2):170-8. PubMed ID: 16569486
[TBL] [Abstract][Full Text] [Related]
22. Ocular devices for the controlled systemic delivery of insulin: in vitro and in vivo dissolution.
Lee YC; Yalkowsky SH
Int J Pharm; 1999 Apr; 181(1):71-7. PubMed ID: 10370204
[TBL] [Abstract][Full Text] [Related]
23. Formulation and characterization of an oily-based system for oral delivery of insulin.
Elsayed A; Remawi MA; Qinna N; Farouk A; Badwan A
Eur J Pharm Biopharm; 2009 Oct; 73(2):269-79. PubMed ID: 19508890
[TBL] [Abstract][Full Text] [Related]
24. Optimization and characterization of controlled release multi-particulate beads coated with starch acetate.
Nutan MT; Soliman MS; Taha EI; Khan MA
Int J Pharm; 2005 Apr; 294(1-2):89-101. PubMed ID: 15814233
[TBL] [Abstract][Full Text] [Related]
25. Response surface methodology to obtain naproxen controlled release tablets from its microspheres with Eudragit L100-55.
Zaghloul AA; Vaithiyalingam SR; Faltinek J; Reddy IK; Khan MA
J Microencapsul; 2001; 18(5):651-62. PubMed ID: 11508770
[TBL] [Abstract][Full Text] [Related]
26. Quality by design - Spray drying of insulin intended for inhalation.
Maltesen MJ; Bjerregaard S; Hovgaard L; Havelund S; van de Weert M
Eur J Pharm Biopharm; 2008 Nov; 70(3):828-38. PubMed ID: 18755270
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
Rekha MR; Sharma CP
J Control Release; 2009 Apr; 135(2):144-51. PubMed ID: 19331862
[TBL] [Abstract][Full Text] [Related]
28. Formulation of a extended release tablet containing dexibuprofen.
Yi HG; Chi MH; Kim YI; Woo JS; Park ES
Arch Pharm Res; 2008 Dec; 31(12):1637-43. PubMed ID: 19099235
[TBL] [Abstract][Full Text] [Related]
29. Controlled release of a self-emulsifying formulation from a tablet dosage form: stability assessment and optimization of some processing parameters.
Nazzal S; Khan MA
Int J Pharm; 2006 Jun; 315(1-2):110-21. PubMed ID: 16563673
[TBL] [Abstract][Full Text] [Related]
30. [Insulin polyamino acid complexes--a variable principle in the preparation of sustained-release forms].
Losse G; Raddatz H; Naumann W; Kossowicz J
Pharmazie; 1988 Feb; 43(2):105-9. PubMed ID: 3293085
[TBL] [Abstract][Full Text] [Related]
31. Preparation and characterization of monomethoxypoly(ethylene glycol)-insulin conjugates.
Zhang M; Dou H; Yin L; Zhang Y; Zhu S; Yin C
Pharmazie; 2009 Mar; 64(3):190-6. PubMed ID: 19348342
[TBL] [Abstract][Full Text] [Related]
32. Investigation of physical and hypoglycaemic properties of rectal suppositories with chosen insulin.
Kosior A
Acta Pol Pharm; 2002; 59(5):353-8. PubMed ID: 12602796
[TBL] [Abstract][Full Text] [Related]
33. Development of a spray congealing process for the preparation of insulin-loaded lipid microparticles and characterization thereof.
Maschke A; Becker C; Eyrich D; Kiermaier J; Blunk T; Göpferich A
Eur J Pharm Biopharm; 2007 Feb; 65(2):175-87. PubMed ID: 17070025
[TBL] [Abstract][Full Text] [Related]
34. Design and statistical optimization of glipizide loaded lipospheres using response surface methodology.
Shivakumar HN; Patel PB; Desai BG; Ashok P; Arulmozhi S
Acta Pharm; 2007 Sep; 57(3):269-85. PubMed ID: 17878108
[TBL] [Abstract][Full Text] [Related]
35. Comparative evaluation of interpolyelectrolyte complexes of chitosan with Eudragit L100 and Eudragit L100-55 as potential carriers for oral controlled drug delivery.
Moustafine RI; Margulis EB; Sibgatullina LF; Kemenova VA; Van den Mooter G
Eur J Pharm Biopharm; 2008 Sep; 70(1):215-25. PubMed ID: 18691856
[TBL] [Abstract][Full Text] [Related]
36. Prolonged antidiabetic effect of zinc-crystallized insulin loaded glycol chitosan nanoparticles in type 1 diabetic rats.
Jo HG; Min KH; Nam TH; Na SJ; Park JH; Jeong SY
Arch Pharm Res; 2008 Jul; 31(7):918-23. PubMed ID: 18704336
[TBL] [Abstract][Full Text] [Related]
37. Insulin nanoparticle preparation and encapsulation into poly(lactic-co-glycolic acid) microspheres by using an anhydrous system.
Han Y; Tian H; He P; Chen X; Jing X
Int J Pharm; 2009 Aug; 378(1-2):159-66. PubMed ID: 19465100
[TBL] [Abstract][Full Text] [Related]
38. Hybrid insulin cocrystals for controlled release delivery.
Brader ML; Sukumar M; Pekar AH; McClellan DS; Chance RE; Flora DB; Cox AL; Irwin L; Myers SR
Nat Biotechnol; 2002 Aug; 20(8):800-4. PubMed ID: 12134168
[TBL] [Abstract][Full Text] [Related]
39. Transglutaminase-mediated modification of ovomucoid: effects on its trypsin inhibitory activity and antigenic properties.
Porta R; Giosafatto CV; di Pierro P; Sorrentino A; Mariniello L
Amino Acids; 2013 Jan; 44(1):285-92. PubMed ID: 22105613
[TBL] [Abstract][Full Text] [Related]
40. [Chemical modification of proteins by "smart" polymers].
Valueva TA; Valuev IL; Obydennova IV; Valuev LI
Bioorg Khim; 2010; 36(6):769-73. PubMed ID: 21317942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
